These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11802199)

  • 21. Combination of p53 expression and p21 loss has an independent prognostic impact on sporadic colorectal cancer.
    Noske A; Lipka S; Budczies J; Müller K; Loddenkemper C; Buhr HJ; Kruschewski M
    Oncol Rep; 2009 Jul; 22(1):3-9. PubMed ID: 19513497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of molecular marker expression can predict clinical outcome in colon carcinomas.
    Galizia G; Lieto E; Ferraraccio F; Orditura M; De Vita F; Castellano P; Imperatore V; Romano C; Ciardiello F; Agostini B; Pignatelli C
    Clin Cancer Res; 2004 May; 10(10):3490-9. PubMed ID: 15161706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of N-myc downstream-regulated gene 1 expression with clinical outcomes of colorectal cancer patients of different race/ethnicity.
    Koshiji M; Kumamoto K; Morimura K; Utsumi Y; Aizawa M; Hoshino M; Ohki S; Takenoshita S; Costa M; Commes T; Piquemal D; Harris CC; Tchou-Wong KM
    World J Gastroenterol; 2007 May; 13(20):2803-10. PubMed ID: 17569115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tissue microarray molecular profiling of early, node-negative adenocarcinoma of the rectum: a comprehensive analysis.
    Hoos A; Nissan A; Stojadinovic A; Shia J; Hedvat CV; Leung DH; Paty PB; Klimstra D; Cordon-Cardo C; Wong WD
    Clin Cancer Res; 2002 Dec; 8(12):3841-9. PubMed ID: 12473598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Re: loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer.
    Manne U; Myers RB; Srivastava S; Grizzle WE
    J Natl Cancer Inst; 1997 Apr; 89(8):585-6. PubMed ID: 9106651
    [No Abstract]   [Full Text] [Related]  

  • 26. P53 overexpression predicts poor chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV colorectal cancers after palliative bowel resection.
    Liang JT; Huang KC; Cheng YM; Hsu HC; Cheng AL; Hsu CH; Yeh KH; Wang SM; Chang KJ
    Int J Cancer; 2002 Feb; 97(4):451-7. PubMed ID: 11802206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular characterization of colorectal neoplasia in translational research.
    Grizzle WE; Manne U; Jhala NC; Weiss HL
    Arch Pathol Lab Med; 2001 Jan; 125(1):91-8. PubMed ID: 11151060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of BMP and activin membrane-bound inhibitor in colorectal cancer.
    Togo N; Ohwada S; Sakurai S; Toya H; Sakamoto I; Yamada T; Nakano T; Muroya K; Takeyoshi I; Nakajima T; Sekiya T; Yamazumi Y; Nakamura T; Akiyama T
    World J Gastroenterol; 2008 Aug; 14(31):4880-8. PubMed ID: 18756595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Are clinicopathological features of colorectal cancers with methylation in half of CpG island methylator phenotype panel markers different from those of CpG island methylator phenotype-high colorectal cancers?
    Bae JM; Rhee YY; Kim KJ; Wen X; Song YS; Cho NY; Kim JH; Kang GH
    Hum Pathol; 2016 Jan; 47(1):85-94. PubMed ID: 26520418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bcl-2 expression and response to chemotherapy in colorectal adenocarcinomas.
    Schneider HJ; Sampson SA; Cunningham D; Norman AR; Andreyev HJ; Tilsed JV; Clarke PA
    Br J Cancer; 1997; 75(3):427-31. PubMed ID: 9020491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoexpression of TS, p53, COX2, EGFR, MSH6 and MLH1 biomarkers and its correlation with degree of differentiation, tumor staging and prognostic factors in colorectal adenocarcinoma: a retrospective longitudinal study.
    Batista WR; Santos G; Vital FMR; Matos D
    Sao Paulo Med J; 2019 May; 137(1):33-38. PubMed ID: 31116268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Micropapillary component in colorectal carcinoma is associated with lymph node metastasis in T1 and T2 Stages and decreased survival time in TNM stages I and II.
    Xu F; Xu J; Lou Z; Di M; Wang F; Hu H; Lai M
    Am J Surg Pathol; 2009 Sep; 33(9):1287-92. PubMed ID: 19471152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of cell cycle and apoptosis regulatory proteins in mismatch repair-proficient colorectal cancer: a tissue microarray-based approach.
    Tornillo L; Lugli A; Zlobec I; Willi N; Glatz K; Lehmann F; Spichtin HP; Maurer R; Stoios D; Sauter G; Terracciano L
    Am J Clin Pathol; 2007 Jan; 127(1):114-23. PubMed ID: 17145638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of p53 codon 72 polymorphism differs with race in colorectal adenocarcinoma.
    Katkoori VR; Jia X; Shanmugam C; Wan W; Meleth S; Bumpers H; Grizzle WE; Manne U
    Clin Cancer Res; 2009 Apr; 15(7):2406-16. PubMed ID: 19339276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytoplasmic localization of p27 (cyclin-dependent kinase inhibitor 1B/KIP1) in colorectal cancer: inverse correlations with nuclear p27 loss, microsatellite instability, and CpG island methylator phenotype.
    Ogino S; Kawasaki T; Ogawa A; Kirkner GJ; Loda M; Fuchs CS
    Hum Pathol; 2007 Apr; 38(4):585-92. PubMed ID: 17239930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical expression of bcl-2 in UICC stage I and III colorectal carcinoma patients: correlation with c-erbB-2, p53, ki-67, CD44, laminin and collagen IV in evaluating prognostic significance.
    Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
    Pol J Pathol; 2006; 57(3):149-59. PubMed ID: 17219742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of SGLT1, Bcl-2 and p53 in primary pancreatic cancer related to survival.
    Casneuf VF; Fonteyne P; Van Damme N; Demetter P; Pauwels P; de Hemptinne B; De Vos M; Van de Wiele C; Peeters M
    Cancer Invest; 2008 Oct; 26(8):852-9. PubMed ID: 18853313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer.
    Smith RA; Tang J; Tudur-Smith C; Neoptolemos JP; Ghaneh P
    Br J Cancer; 2011 Apr; 104(9):1440-51. PubMed ID: 21448172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does biomolecular characterization of stage II/III colorectal cancer have any prognostic value?
    Funaioli C; Pinto C; Mutri V; Di Fabio F; Ceccarelli C; Martoni AA
    Clin Colorectal Cancer; 2006 May; 6(1):38-45. PubMed ID: 16796790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical relevance of transforming growth factor alpha, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors.
    De Jong KP; Stellema R; Karrenbeld A; Koudstaal J; Gouw AS; Sluiter WJ; Peeters PM; Slooff MJ; De Vries EG
    Hepatology; 1998 Oct; 28(4):971-9. PubMed ID: 9755233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.